The fulminant index: A method of rapidly differentiating fulminant type 1 diabetes from diabetic ketoacidosis. 2022

Junlin Qiu, and Xia Li, and Wen Chen, and Xiaoxi Ma, and Zhiguo Xie, and Gan Huang, and Shuoming Luo, and Zhiguang Zhou
Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.

Fulminant type 1 diabetes (FT1D) could present diabetes ketoacidosis (DKA) at early onset. It is crucial to identify FT1D from DKA manifestations in time at clinical practice. This study was aimed at investigating whether the fulminant index (FI), encompassing plasma glucose (PG) to glycated haemoglobin (HbA1c) ratio (PG/HbA1c), serum potassium ion (K+ ) to HbA1c ratio (K+ /HbA1c) and serum sodium ion (Na+ ) multiplied by HbA1c (Na+ *HbA1c), is a feasible indicator for early FT1D diagnosis. A total of 78 subjects were enroled, including 40 FT1D patients and 38 non-FT1D patients with DKA. We utilised receiver operating characteristic (ROC) curve analysis to determine the FI cut-off values between FT1D and non-FT1D groups and examined efficacies of FI based on statistics. ROC curve analyses showed that the maximum Youden's index for PG/HbA1c bonding to a cut-off value of 4.389, with the sensitivity of 75.0% and specificity of 81.6% in identifying FT1D from DKA. And optimal K+ /HbA1c cut-off value was 0.728 with a sensitivity of 90.0% and specificity of 84.2%. For Na+ *HbA1c, the best cut-off value was 923.65, and its sensitivity and specificity were 85% and 73.7%, respectively. These results suggested FI could work as a valid and convenient indicator for differentiating FT1D from initial DKA patients. FI (K+ /HbA1c) presented the best efficacy as an independent index.

UI MeSH Term Description Entries
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D006442 Glycated Hemoglobin Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN (occurring as a minor fraction of the hemoglobin of ERYTHROCYTES.) It generally refers to glycated HEMOGLOBIN A. Hemoglobin A1c (Hb A1c) is hemoglobin A with GLYCATION on a terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes. Fructated Hemoglobins,Glycohemoglobin,Glycohemoglobin A,Glycohemoglobins,Glycosylated Hemoglobin A,Hb A1c,HbA1,Hemoglobin A(1),Hemoglobin A, Glycosylated,Glycated Hemoglobin A,Glycated Hemoglobin A1c,Glycated Hemoglobins,Glycosylated Hemoglobin A1c,Hb A1,Hb A1a+b,Hb A1a-1,Hb A1a-2,Hb A1b,Hemoglobin, Glycated A1a-2,Hemoglobin, Glycated A1b,Hemoglobin, Glycosylated,Hemoglobin, Glycosylated A1a-1,Hemoglobin, Glycosylated A1b,A1a-1 Hemoglobin, Glycosylated,A1a-2 Hemoglobin, Glycated,A1b Hemoglobin, Glycated,A1b Hemoglobin, Glycosylated,Glycated A1a-2 Hemoglobin,Glycated A1b Hemoglobin,Glycosylated A1a-1 Hemoglobin,Glycosylated A1b Hemoglobin,Glycosylated Hemoglobin,Hemoglobin A, Glycated,Hemoglobin A1c, Glycated,Hemoglobin A1c, Glycosylated,Hemoglobin, Glycated,Hemoglobin, Glycated A1a 2,Hemoglobin, Glycosylated A1a 1,Hemoglobins, Fructated,Hemoglobins, Glycated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012372 ROC Curve A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli. ROC Analysis,Receiver Operating Characteristic,Analysis, ROC,Analyses, ROC,Characteristic, Receiver Operating,Characteristics, Receiver Operating,Curve, ROC,Curves, ROC,ROC Analyses,ROC Curves,Receiver Operating Characteristics
D016883 Diabetic Ketoacidosis A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA. Acidosis, Diabetic,DKA Diabetic Ketoacidosis,Diabetic Acidosis,Diabetic Ketosis,Ketoacidosis, Diabetic,Ketosis, Diabetic,Acidoses, Diabetic,DKA Diabetic Ketoacidoses,Diabetic Acidoses,Diabetic Ketoacidoses,Diabetic Ketoacidosis, DKA,Diabetic Ketoses,Ketoacidoses, Diabetic,Ketoacidosis, DKA Diabetic,Ketoses, Diabetic

Related Publications

Junlin Qiu, and Xia Li, and Wen Chen, and Xiaoxi Ma, and Zhiguo Xie, and Gan Huang, and Shuoming Luo, and Zhiguang Zhou
February 2019, Annales d'endocrinologie,
Junlin Qiu, and Xia Li, and Wen Chen, and Xiaoxi Ma, and Zhiguo Xie, and Gan Huang, and Shuoming Luo, and Zhiguang Zhou
May 2002, Obstetrics and gynecology,
Junlin Qiu, and Xia Li, and Wen Chen, and Xiaoxi Ma, and Zhiguo Xie, and Gan Huang, and Shuoming Luo, and Zhiguang Zhou
August 2023, Oxford medical case reports,
Junlin Qiu, and Xia Li, and Wen Chen, and Xiaoxi Ma, and Zhiguo Xie, and Gan Huang, and Shuoming Luo, and Zhiguang Zhou
February 2015, Journal of the Intensive Care Society,
Junlin Qiu, and Xia Li, and Wen Chen, and Xiaoxi Ma, and Zhiguo Xie, and Gan Huang, and Shuoming Luo, and Zhiguang Zhou
October 2016, Acta diabetologica,
Junlin Qiu, and Xia Li, and Wen Chen, and Xiaoxi Ma, and Zhiguo Xie, and Gan Huang, and Shuoming Luo, and Zhiguang Zhou
April 2003, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Junlin Qiu, and Xia Li, and Wen Chen, and Xiaoxi Ma, and Zhiguo Xie, and Gan Huang, and Shuoming Luo, and Zhiguang Zhou
January 2018, The Turkish journal of pediatrics,
Junlin Qiu, and Xia Li, and Wen Chen, and Xiaoxi Ma, and Zhiguo Xie, and Gan Huang, and Shuoming Luo, and Zhiguang Zhou
January 2025, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi,
Junlin Qiu, and Xia Li, and Wen Chen, and Xiaoxi Ma, and Zhiguo Xie, and Gan Huang, and Shuoming Luo, and Zhiguang Zhou
August 2019, Molecular and clinical oncology,
Junlin Qiu, and Xia Li, and Wen Chen, and Xiaoxi Ma, and Zhiguo Xie, and Gan Huang, and Shuoming Luo, and Zhiguang Zhou
July 2011, BMJ (Clinical research ed.),
Copied contents to your clipboard!